Add BrightSurf on Google Email

New York- Presbyterian Hospital/Columbia University Medical Center


Deep inside the body, tiny mechanical microscope

A new technology is being used to diagnose illnesses in hard-to-reach areas of the body, but specialists need standardized guidelines to improve accuracy. The study found poor agreement among doctors on the clinical significance of images from the tiny microscope, highlighting the need for improved training and standardization.

SourceNew York- Presbyterian Hospital/Columbia University Medical Center·JournalDigestive Diseases and Sciences·DateAug 14, 2012

New prenatal genetic test is much more powerful at detecting fetal abnormalities

A nationwide study has found that chromosomal microarray testing detects additional genetic abnormalities in about 1 in 70 normal karyotype samples and 6% of cases with structural abnormalities. The new test may soon replace standard karyotyping for prenatal testing, providing more information on potential disorders.

SourceNew York- Presbyterian Hospital/Columbia University Medical Center·JournalAmerican Journal of Obstetrics and Gynecology·DateFeb 9, 2012

NY Presbyterian/Columbia research presented at Digestive Disease Week meeting

Researchers from NY Presbyterian/Columbia University Medical Center present studies on the prevalence of colorectal adenomas in racial and ethnic minorities, finding higher rates among blacks and Hispanics. Additionally, a study on single operator choledochoscopy reveals low interobserver agreement and accuracy among experts, highlight...

Clinical trial establishes catheter-based aortic valve replacement as new standard of care for patients

A multicenter study published in the New England Journal of Medicine shows that transcatheter aortic-valve implantation resulted in significantly lower rates of death among patients who cannot undergo surgery. The procedure demonstrated safety and effectiveness for this life-threatening illness in unsuitable candidates.

SourceNew York- Presbyterian Hospital/Columbia University Medical Center·JournalNew England Journal of Medicine·DateSep 22, 2010

NewYork-Presbyterian/Weill Cornell physician-scientists present at 2010 American Urological Meeting

Physician-scientists from NewYork-Presbyterian Hospital/Weill Cornell Medical Center present several studies at the 2010 American Urological Meeting, including a potential breakthrough in using 5-alpha reductase inhibitors to improve PSA test accuracy for prostate cancer diagnosis. Additionally, they present results on robotic surgery ...

Strategy to help doctors determine when to treat retinopathy of prematurity

Researchers have identified key eye characteristics to determine which premature infants are most likely to benefit from early treatment for retinopathy of prematurity, resulting in improved vision and reduced risk of blindness. This new approach aims to improve the lives of thousands of children born prematurely each year.

Hypospadias, a birth defect of the male urethra, is not increasing in New York state

A study by researchers at NewYork-Presbyterian Hospital/Columbia University Medical Center has found no statistically significant increase in hypospadias rates in New York State during the 1992-2005 period, contradicting earlier concerns about environmental chemicals. Maternal age is a significant risk factor for the birth defect.

NewYork-Presbyterian/Columbia physician-scientists present at 2009 American Transplant Congress

Physician-scientists presented new research on minimizing steroid exposure for liver transplant patients with hepatitis C, hypothermic machine perfusion vs. cold storage for preserving donor livers, and the effectiveness of neutrophil-lymphocyte ratio in predicting colorectal liver metastases. The studies aimed to improve patient outco...

NEJM study finds drug-eluting stents more effective than bare-metal stents in heart attack patients

A landmark study published in NEJM found that paclitaxel-eluting stents significantly reduce target lesion revascularization and binary angiographic restenosis rates compared to bare-metal stents. The study showed a lower rate of ischemia-driven target-lesion revascularization at 12 months with the use of paclitaxel-eluting stents.

SourceNew York- Presbyterian Hospital/Columbia University Medical Center·JournalNew England Journal of Medicine·DateMay 26, 2009

New York-Presbyterian/Columbia physician-scientists present at ACC's 57th Annual Scientific Session

Researchers from NewYork-Presbyterian Hospital/Columbia University Medical Center presented findings on the effectiveness of drug-eluting stents in preventing restenosis. The studies also explored the safety and efficacy of bivalirudin for patients undergoing primary angioplasty, particularly those with diabetes and advanced age.

Newly discovered antibody may be body's natural defense against Alzheimer's

Researchers identified naturally occurring antibodies in human blood that selectively target toxic beta amyloid oligomers, potentially offering a natural defense mechanism against Alzheimer's. The antibodies recognize misfolded shapes of proteins, which could have implications for immune therapy of other neurodegenerative diseases.